Merck & Co. Inc. (MRK)

89.10
0.38 0.43
NYSE : Health Technology
Prev Close 88.72
Open 88.60
Day Low/High 88.51 / 89.53
52 Wk Low/High 70.89 / 89.53
Volume 8.27M
Avg Volume 8.30M
Exchange NYSE
Shares Outstanding 2.55B
Market Cap 225.88B
EPS 2.30
P/E Ratio 41.65
Div & Yield 2.44 (2.48%)
Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

It was a down day across the board on Wall Street.

Cramer: We're Seeing the Best of Times and the Worst of Times at the Same Time

Cramer: We're Seeing the Best of Times and the Worst of Times at the Same Time

It depends on which aisle of the stock market you're on.

Which Way Are These Stocks Going?

Which Way Are These Stocks Going?

Finding bullish and bearish reversals in the market.

Merck's Price Strength Is Ailing

Merck's Price Strength Is Ailing

Even if the stock bounces, an advance is unlikely.

Midday Update: Stocks Mixed as Healthcare Struggles, Tech Continues Gains

Midday Update: Stocks Mixed as Healthcare Struggles, Tech Continues Gains

Stocks were mixed at midday Monday as Merck weighed on the Dow and tech strength boosted the Nasdaq.

3 Small-Caps on My Growth Stock Radar

3 Small-Caps on My Growth Stock Radar

LGI Homes, ANI Pharmaceuticals and Sonus Networks are worth considering.

Stop Worrying About Valuations After Amazon, Alphabet and Microsoft's Earnings

Stop Worrying About Valuations After Amazon, Alphabet and Microsoft's Earnings

The revenue and profit gains from some of the biggest technology companies like Amazon AMZN, Alphabet GOOGL and Microsoft MSFT show that valuations aren't so stretched.

There Is Sound Fundamental Reasoning Behind the Positivity: Market Recon

There Is Sound Fundamental Reasoning Behind the Positivity: Market Recon

The ECB's super dovish message was good for the markets.

Alphabet, Amazon and Expedia: This Is What You Must Know on Friday

Alphabet, Amazon and Expedia: This Is What You Must Know on Friday

U.S. futures point a higher open following earnings beats from Amazon, Alphabet and Microsoft after the bell on Thursday.

Cramer: What's Tax Reform Got to Do With It?

Cramer: What's Tax Reform Got to Do With It?

Treasury secretary says it's baked into the market, but is anyone really counting on it?

KalVista Shares Skyrocket On Merck Collaboration, Ovid Pops -- Biotech Movers

KalVista Shares Skyrocket On Merck Collaboration, Ovid Pops -- Biotech Movers

Cambridge, Mass.-based KalVista Pharmaceuticals on Oct. 10 unveiled a collaboration pact with Merck.

Positive Signs in Drug Distribution

Positive Signs in Drug Distribution

Blockbuster drugs still need companies to deliver them.

Intermediate Trade: Merck & Co

Intermediate Trade: Merck & Co

Try this bearishly biased, in-the-money vertical put spread on MRK.

Cramer: Got the Apple-FANG Blues? Look for a Rotation

Cramer: Got the Apple-FANG Blues? Look for a Rotation

There's one going on now.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

Cramer: August Finally Arrives

Cramer: August Finally Arrives

There are plenty of reasons for the selloff, not the least of which is White House chaos.

President Trump Has Disbanded His Manufacturing Council

President Trump Has Disbanded His Manufacturing Council

Pressure is mounting on CEOs to step down from President Donald Trump's American Manufacturing Council

CEOs Dump Donald Trump

CEOs Dump Donald Trump

CEOs exit President's Council after Charlottesville response

Daily Market Preview: CEOs Dump Trump & Activists Stir the Danone Pot

Daily Market Preview: CEOs Dump Trump & Activists Stir the Danone Pot

CEOs exit President's Council after Charlottesville response

North Korea Dials Down Tensions With United States, Stocks Higher

North Korea Dials Down Tensions With United States, Stocks Higher

North Korea says it will delay a decision on attacking Guam.

Rev's Forum: Bears' Fundamental Arguments Lose Out to Price Patterns

Rev's Forum: Bears' Fundamental Arguments Lose Out to Price Patterns

The problem for the pessimists is the same one that has plagued them since the election -- the price action is not cooperating.

Cramer: This Is Why You Keep Cash on Hand

Cramer: This Is Why You Keep Cash on Hand

Because the selloff isn't over.

President Trump Condemns Hate Groups, Days After Charlottesville Attack

President Trump Condemns Hate Groups, Days After Charlottesville Attack

Days after the deadly attack in Charlottesville, President Trump comes out with his strongest condemnation yet of the hate groups who rallied there.

Jim Cramer on Merck, Bitcoin, Nvidia, Netflix, Disney, Procter & Gamble, TJX and Home Depot

Jim Cramer on Merck, Bitcoin, Nvidia, Netflix, Disney, Procter & Gamble, TJX and Home Depot

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer analyzes Monday's trending stocks.

Jim Cramer on Merck CEO Ken Frazier: Everyone Has a Right to Speak Their Mind

Jim Cramer on Merck CEO Ken Frazier: Everyone Has a Right to Speak Their Mind

Merck CEO Ken Frazier is leaving Trump's business council.

Cramer: FANG and the Lessons of History

Cramer: FANG and the Lessons of History

What a difference 2 years make -- or 17.

Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly

Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly

Merck vs. Eli Lilly.

Jim Cramer on Amazon, Tesla, Starbucks, Exxon, Chevron, American Airlines, Southwest Airlines, Merck and Tax Reform

Jim Cramer on Amazon, Tesla, Starbucks, Exxon, Chevron, American Airlines, Southwest Airlines, Merck and Tax Reform

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Friday's trending stocks.

Does Merck's Rally Have Legs?

Does Merck's Rally Have Legs?

MRK has shaped up on the charts.